Important Notice for ModivCare Inc. Shareholders: Potential Securities Class Action Lawsuit
New York, NY, March 10, 2025 – The Gross Law Firm, a leading national securities fraud law firm, issues the following notice to all persons who purchased or otherwise acquired ModivCare Inc. (MODV) securities between January 1, 2023, and December 31, 2024, inclusive (the “Class Period”).
Background
ModivCare Inc., a healthcare services company, is under investigation for possible securities fraud. The investigation stems from allegations that the Company and certain of its officers or directors may have made false and/or misleading statements and/or failed to disclose material information during the Class Period.
Class Action Lawsuit
If you are a shareholder who purchased ModivCare securities during the Class Period, you may be entitled to compensation. The Gross Law Firm, with offices in New York, San Francisco, Los Angeles, and Washington D.C., is leading the charge in this securities class action lawsuit and encourages all shareholders to contact the firm regarding potential lead plaintiff appointment. If you wish to serve as a lead plaintiff, you must move the Court no later than the lead plaintiff deadline. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
Possible Impact on Shareholders
If the allegations against ModivCare prove to be true, shareholders may have suffered significant losses. As a result of the Company’s alleged misconduct, the value of MODV securities was artificially inflated, causing damages to investors. The lead plaintiff in this action may be able to recover damages on behalf of the class, including monetary losses and any out-of-pocket costs incurred as a result of the alleged fraud.
Potential Impact on the World
The consequences of securities fraud can extend beyond the affected investors. When a publicly-traded company engages in fraudulent activities, it can harm the broader financial markets and erode investor confidence. In this case, if the allegations against ModivCare are proven, it could send a message to other companies in the healthcare sector and the business community as a whole that such misconduct will not be tolerated.
Conclusion
The Gross Law Firm reminds ModivCare shareholders of the importance of protecting their investments and taking action when necessary. If you purchased MODV securities during the Class Period, we urge you to contact us regarding potential lead plaintiff appointment. Our experienced securities fraud attorneys are dedicated to fighting for the rights of investors and ensuring that companies are held accountable for their actions.
- If you purchased ModivCare securities during the Class Period, you may be entitled to compensation.
- The Gross Law Firm is leading the charge in this securities class action lawsuit.
- Shareholders may be able to recover damages, including monetary losses and out-of-pocket costs.
- If the allegations against ModivCare are proven, it could send a message to other companies in the healthcare sector and beyond.
